311 related articles for article (PubMed ID: 15210552)
1. The effects of transtympanic micropressure treatment in people with unilateral Meniere's disease.
Gates GA; Green JD; Tucci DL; Telian SA
Arch Otolaryngol Head Neck Surg; 2004 Jun; 130(6):718-25. PubMed ID: 15210552
[TBL] [Abstract][Full Text] [Related]
2. Meniett clinical trial: long-term follow-up.
Gates GA; Verrall A; Green JD; Tucci DL; Telian SA
Arch Otolaryngol Head Neck Surg; 2006 Dec; 132(12):1311-6. PubMed ID: 17178941
[TBL] [Abstract][Full Text] [Related]
3. Intermittent pressure therapy of intractable Ménière's disease using the Meniett device: a preliminary report.
Gates GA; Green JD
Laryngoscope; 2002 Aug; 112(8 Pt 1):1489-93. PubMed ID: 12172267
[TBL] [Abstract][Full Text] [Related]
4. Effect of transtympanic low-pressure therapy in patients with unilateral Menière's disease unresponsive to betahistine: a randomised, placebo-controlled, double-blinded, clinical trial.
Gürkov R; Filipe Mingas LB; Rader T; Louza J; Olzowy B; Krause E
J Laryngol Otol; 2012 Apr; 126(4):356-62. PubMed ID: 22365373
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Meniere's disease with the low-pressure pulse generator (Meniett device).
Gates GA
Expert Rev Med Devices; 2005 Sep; 2(5):533-7. PubMed ID: 16293064
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.
Rajan GP; Din S; Atlas MD
J Laryngol Otol; 2005 May; 119(5):391-5. PubMed ID: 15949105
[TBL] [Abstract][Full Text] [Related]
7. The effect of the Meniett device in patients with Ménière's disease: long-term results.
Dornhoffer JL; King D
Otol Neurotol; 2008 Sep; 29(6):868-74. PubMed ID: 18617868
[TBL] [Abstract][Full Text] [Related]
8. Positive pressure therapy for Ménière's disease or syndrome.
van Sonsbeek S; Pullens B; van Benthem PP
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD008419. PubMed ID: 25756795
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
Garduño-Anaya MA; Couthino De Toledo H; Hinojosa-González R; Pane-Pianese C; Ríos-Castañeda LC
Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Ménière's Disease Patient-Oriented Symptom-Severity Index.
Gates GA; Verrall AM
Arch Otolaryngol Head Neck Surg; 2005 Oct; 131(10):863-7. PubMed ID: 16230587
[TBL] [Abstract][Full Text] [Related]
11. Local pressure protocol, including Meniett, in the treatment of Ménière's disease: short-term results during the active stage.
Barbara M; Consagra C; Monini S; Nostro G; Harguindey A; Vestri A; Filipo R
Acta Otolaryngol; 2001 Dec; 121(8):939-44. PubMed ID: 11813899
[TBL] [Abstract][Full Text] [Related]
12. Intermittent pressure therapy of intractable Meniere's disease and delayed endolymphatic hydrops using the transtympanic membrane massage device: a preliminary report.
Watanabe Y; Shojaku H; Junicho M; Asai M; Fujisaka M; Takakura H; Tsubota M; Yasumura S
Acta Otolaryngol; 2011 Nov; 131(11):1178-86. PubMed ID: 21838607
[TBL] [Abstract][Full Text] [Related]
13. [Middle ear overpressure with Meniett in Menière disease: indications, results at short and middle terms in 53 cases].
Faict H; Bouccara D
Rev Laryngol Otol Rhinol (Bord); 2007; 128(1-2):33-6. PubMed ID: 17633662
[TBL] [Abstract][Full Text] [Related]
14. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
Wu IC; Minor LB
Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
[TBL] [Abstract][Full Text] [Related]
15. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.
Casani A; Nuti D; Franceschini SS; Gaudini E; Dallan I
Otolaryngol Head Neck Surg; 2005 Dec; 133(6):929-35. PubMed ID: 16360516
[TBL] [Abstract][Full Text] [Related]
16. Initial UK experience of patient satisfaction with the Meniett® device for Ménière's disease treatment.
Buchanan MA; Rai A; Prinsley PR
J Laryngol Otol; 2010 Oct; 124(10):1067-72. PubMed ID: 20537216
[TBL] [Abstract][Full Text] [Related]
17. Immediate effects of middle ear pressure changes on the electrocochleographic recordings in patients with Menière's disease: a clinical placebo-controlled study.
Densert B; Densert O; Arlinger S; Sass K; Odkvist L
Am J Otol; 1997 Nov; 18(6):726-33. PubMed ID: 9391668
[TBL] [Abstract][Full Text] [Related]
18. Effects of middle ear pressure changes on clinical symptoms in patients with Ménière's disease--a clinical multicentre placebo-controlled study.
Odkvist LM; Arlinger S; Billermark E; Densert B; Lindholm S; Wallqvist J
Acta Otolaryngol Suppl; 2000; 543():99-101. PubMed ID: 10908991
[TBL] [Abstract][Full Text] [Related]
19. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
[TBL] [Abstract][Full Text] [Related]
20. Meniett therapy may avoid vestibular neurectomy in disabling Meniere's disease.
Barbara M; Monini S; Chiappini I; Filipo R
Acta Otolaryngol; 2007 Nov; 127(11):1136-41. PubMed ID: 17851896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
